Related references
Note: Only part of the references are listed.Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
Jozine M. ter Maaten et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
Frank Bienaime et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
Hidekazu Sugiura et al.
PLOS ONE (2018)
FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction
Edward R. Smith et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia
Maria L. Mace et al.
KIDNEY INTERNATIONAL (2017)
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
Edward R. Smith et al.
SCIENTIFIC REPORTS (2017)
Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
Svetlana Slavic et al.
SCIENTIFIC REPORTS (2017)
Cardiac actions of fibroblast growth factor 23
Christian Faul
BONE (2017)
Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD
Rukshana Shroff et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
Ingrid A. Andersen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Up-regulation of FGF23 release by aldosterone
Bingbing Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients
Margarida Sarmento-Dias et al.
CLINICAL NEPHROLOGY (2016)
The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
Alexander Grabner et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment
Abul Fajol et al.
FASEB JOURNAL (2016)
Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages
Xiaobin Han et al.
FEBS LETTERS (2016)
Genetic insights into the mechanisms of Fgf signaling
J. Richard Brewer et al.
GENES & DEVELOPMENT (2016)
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
Saurav Singh et al.
KIDNEY INTERNATIONAL (2016)
Update on FGF23 and Klotho signaling
Reinhold G. Erben
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
Beatrice Richter et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage The Northern Manhattan Study
Clinton B. Wright et al.
STROKE (2016)
Therapeutics Targeting FGF Signaling Network in Human Diseases
Masaru Katoh
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
Huixin Hao et al.
ONCOTARGET (2016)
Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
Suguru Tanaka et al.
PLOS ONE (2016)
FGF23 from bench to bedside
Csaba P. Kovesdy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Roles of FGF Signals in Heart Development, Health, and Disease
Nobuyuki Itoh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During Renin-Angiotensin-Aldosterone System Blockade
Jelmer K. Humalda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Alexander Grabner et al.
CELL METABOLISM (2015)
Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
Ryan A. Frieler et al.
CIRCULATION (2015)
Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
Olena Andrukhova et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
Manfred Richter et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction
Edward P. Carter et al.
TRENDS IN CELL BIOLOGY (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
Peter Wohlfahrt et al.
JACC-HEART FAILURE (2015)
Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease
Miki Imazu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population The Multi-Ethnic Study of Atherosclerosis
Bryan Kestenbaum et al.
CIRCULATION-HEART FAILURE (2014)
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease
Myles Wolf et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Anti-fibroblast growth factor 23 antibody therapy
Seiji Fukumoto
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
Jacob A. Udell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease
Daniela Spichtig et al.
KIDNEY INTERNATIONAL (2014)
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
Julia J. Scialla et al.
NATURE REVIEWS NEPHROLOGY (2014)
FGF23 protein expression in coronary arteries is associated with impaired kidney function
Natalie A. van Venrooij et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Plasma FGF23 and the risk of stroke The Northern Manhattan Study (NOMAS)
Clinton B. Wright et al.
NEUROLOGY (2014)
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S. Tagliabracci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Fibroblast Growth Factor-23 and Cardiac Structure and Function
Isha Agarwal et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
Chad D. Touchberry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
Leandro C. Baia et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Nuclear Fibroblast Growth Factor 2 (FGF2) Isoforms Inhibit Bone Marrow Stromal Cell Mineralization Through FGF23/FGFR/MAPK In Vitro
Liping Xiao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Loss of Klotho Contributes to Kidney Injury by Derepression of Wnt/β-Catenin Signaling
Lili Zhou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
Johan Arnlov et al.
KIDNEY INTERNATIONAL (2013)
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Julia J. Scialla et al.
KIDNEY INTERNATIONAL (2013)
Exploring mechanisms of FGF signalling through the lens of structural biology
Regina Goetz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
The Role of Fibroblast Growth Factor-23 in Cardiorenal Syndrome
Csaba P. Kovesdy et al.
NEPHRON CLINICAL PRACTICE (2013)
Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure
Tamara Isakova et al.
PEDIATRIC NEPHROLOGY (2013)
Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
Kensaku Shibata et al.
PLOS ONE (2013)
Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor
Cristina Zanchi et al.
PLOS ONE (2013)
Pathophysiological roles of FGF signaling in the heart
Nobuyuki Itoh et al.
FRONTIERS IN PHYSIOLOGY (2013)
Signaling network of Oncostatin M pathway
Gourav Dey et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)
Fibroblast Growth Factor 23 and Inflammation in CKD
Fair Aunoz Mendoza et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Fibroblast growth factor 23 and the heart
Christian Faul
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism
L. Darryl Quarles
NATURE REVIEWS ENDOCRINOLOGY (2012)
FGF-23: the rise of a novel cardiovascular risk marker in CKD
Gunnar H. Heine et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model
Bing Dai et al.
PLOS ONE (2012)
Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis
Wacharee Seeherunvong et al.
PEDIATRIC NEPHROLOGY (2012)
Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling
Thomas Kubin et al.
CELL STEM CELL (2011)
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target
Anna P. Lam et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
Sarah Seiler et al.
EUROPEAN HEART JOURNAL (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
Nobuyuki Itoh et al.
JOURNAL OF BIOCHEMISTRY (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
Alper Kirkpantur et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Intramyocardial Fibroblast Myocyte Communication
Rahul Kakkar et al.
CIRCULATION RESEARCH (2010)
Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
Mathias Voigt et al.
HISTOPATHOLOGY (2010)
Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO
Liping Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
Mahmut I. Yilmaz et al.
KIDNEY INTERNATIONAL (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
Mohamed M. Nasrallah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Sarah Seiler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
MEDICAL PROGRESS Hemodialysis
Jonathan Himmelfarb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
Heng Jung Hsu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutierrez et al.
CIRCULATION (2009)
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Jyothsna Gattineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis
Ken Arita et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The parathyroid is a target organ for FGF23 in rats
Iddo Z. Ben-Dov et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels
Mitchell Goldfarb et al.
NEURON (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1
Zhi-Sheng Jiang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Regulation of fibroblast growth factor-23 signaling by Klotho
H Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Acute heart failure syndromes -: Current state and framework for future research
M Gheorghiade et al.
CIRCULATION (2005)
Structural basis for fibroblast growth factor receptor activation
M Mohammadi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Evolution of the Fgf and Fgfr gene families
N Itoh et al.
TRENDS IN GENETICS (2004)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Oncostatin M activates Stat DNA binding and transcriptional activity in primary human fetal astrocytes: Low and high-passage cells have distinct patterns of stat activation
LK Schaefer et al.
CYTOKINE (2000)
Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38
NJ Van Wagoner et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
